ReP USP - Resultado da busca

Filtros : "2013" "Immunotherapy" "ICB" Removidos: "Biologia Celular e Tecidaul" "FISIOLOGIA HUMANA" "DIABETES MELLITUS" "Nunes, Maria Tereza" "BITTENCOURT, JACKSON CIONI" "HU" Limpar

Filtros

Artigo de periodico-carta/editorial
Are dysfunctional monocyte-derived dendritic cells in cancer an explanation for cancer vaccine failures? (2013)
Barbuto, José Alexandre Marzagão
Source: Immunotherapy. Unidade: ICB
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARBUTO, José Alexandre Marzagão. Are dysfunctional monocyte-derived dendritic cells in cancer an explanation for cancer vaccine failures?. Immunotherapy. Londres: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.2217/imt.12.153. Acesso em: 15 nov. 2024. , 2013
APA
Barbuto, J. A. M. (2013). Are dysfunctional monocyte-derived dendritic cells in cancer an explanation for cancer vaccine failures? Immunotherapy. Londres: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.2217/imt.12.153
NLM
Barbuto JAM. Are dysfunctional monocyte-derived dendritic cells in cancer an explanation for cancer vaccine failures? [Internet]. Immunotherapy. 2013 ; 5( 2): 105-107.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2217/imt.12.153
Vancouver
Barbuto JAM. Are dysfunctional monocyte-derived dendritic cells in cancer an explanation for cancer vaccine failures? [Internet]. Immunotherapy. 2013 ; 5( 2): 105-107.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2217/imt.12.153
Artigo de periodico
Autologous and allogenic systems of HIV expansion: what is the better choice for clinical application in therapeutic vaccine? (2013)
Silva, Lais Teodoro da; Pontillo, Alessandra ; Silva, Wanessa Cardoso da; Almeida, Alexandre de; Duarte, Alberto José da Silva; Oshiro, Telma Miyuki
Source: Immunotherapy. Unidades: ICB, FM
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Lais Teodoro da et al. Autologous and allogenic systems of HIV expansion: what is the better choice for clinical application in therapeutic vaccine?. Immunotherapy, v. 5, n. 12, p. 1305-1311, 2013Tradução . . Disponível em: https://doi.org/10.2217/imt.13.136. Acesso em: 15 nov. 2024.
APA
Silva, L. T. da, Pontillo, A., Silva, W. C. da, Almeida, A. de, Duarte, A. J. da S., & Oshiro, T. M. (2013). Autologous and allogenic systems of HIV expansion: what is the better choice for clinical application in therapeutic vaccine? Immunotherapy, 5( 12), 1305-1311. doi:10.2217/imt.13.136
NLM
Silva LT da, Pontillo A, Silva WC da, Almeida A de, Duarte AJ da S, Oshiro TM. Autologous and allogenic systems of HIV expansion: what is the better choice for clinical application in therapeutic vaccine? [Internet]. Immunotherapy. 2013 ; 5( 12): 1305-1311.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2217/imt.13.136
Vancouver
Silva LT da, Pontillo A, Silva WC da, Almeida A de, Duarte AJ da S, Oshiro TM. Autologous and allogenic systems of HIV expansion: what is the better choice for clinical application in therapeutic vaccine? [Internet]. Immunotherapy. 2013 ; 5( 12): 1305-1311.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2217/imt.13.136

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024